Laurel Organics Ltd


Company description

Kimia / Laurel is engaged in manufacturing wide range of  APIs and Intermediates addressing to high potential therapeutic segments such as  Anti-Hypertensive, Anti-Diabetic, Anti-Inflammatory, Anti-Emetic, Gastro-Intestinal Agent, Calcium Challel Blocker etc. •Our dedicated world class Research & Development Center is approved by Department of Scientific and Industrial Research, Ministry of  Science & Technology, Government of India. •The state-of-the-art Manufacturing facility (Laurel Organics) is spread over 6 acres of land and the facility is as per the global cGMP Standards and awarded with GMP certificate by State Drugs Controller, FDA, Haryana in July, 2017 • We also offer Contract Manufacturing activities.  Our Major APIs include Levosulpiride, Rosuvastatin, Citicoline, Cilnidipine, Urseodeoxy Cholic Acid, Tranexamic Acid, Sitagliptin, Benfotiamine, Gliclazide, Obeticholic Acid, Acotiamide, etc

Quick facts

Sales markets Eastern Europe; Middle East; Asia; Central/South America
Primary business activity Manufacturer
Affiliated categories: API Contract Manufacturing |Exclusive Synthesis of APIs |APIs More

Recently at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 7F43A See our Exhibitor Profile   See full Exhibitor List
24 oct 2017

CPhI Worldwide 2017

24 - 26 October 2017 Messe Frankfurt, Germany We were at stand 111F74NEP See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with Laurel Organics Ltd

Laurel Organics Ltd

Contact information




View all contact information